Kreisberg Jason F, Yonemoto Wes, Greene Warner C
Gladstone Institute of Virology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA.
J Exp Med. 2006 Apr 17;203(4):865-70. doi: 10.1084/jem.20051856. Epub 2006 Apr 10.
Human immunodeficiency virus (HIV) can infect resting CD4 T cells residing in lymphoid tissues but not those circulating in peripheral blood. The molecular mechanisms producing this difference remain unknown. We explored the potential role of the tissue microenvironment and its influence on the action of the antiviral factor APOBEC3G (A3G) in regulating permissivity to HIV infection. We found that endogenous IL-2 and -15 play a key role in rendering resident naive CD4 T cells susceptible to HIV infection. Infection of memory CD4 T cells also requires endogenous soluble factors, but not IL-2 or -15. A3G is found in a high molecular mass complex in HIV infection-permissive, tissue-resident naive CD4 T cells but resides in a low molecular mass form in nonpermissive, blood-derived naive CD4 T cells. Upon treatment with endogenous soluble factors, these cells become permissive for HIV infection, as low molecular mass A3G is induced to assemble into high molecular mass complexes. These findings suggest that in lymphoid tissues, endogenous soluble factors, likely including IL-2 and -15 and others, stimulate the formation of high molecular mass A3G complexes in tissue-resident naive CD4 T cells, thereby relieving the potent postentry restriction block for HIV infection conferred by low molecular mass A3G.
人类免疫缺陷病毒(HIV)可感染存在于淋巴组织中的静止CD4 T细胞,但不能感染在外周血中循环的CD4 T细胞。产生这种差异的分子机制尚不清楚。我们探讨了组织微环境的潜在作用及其对抗病毒因子载脂蛋白B mRNA编辑酶催化多肽样蛋白3G(APOBEC3G,A3G)调节HIV感染易感性作用的影响。我们发现内源性白细胞介素-2(IL-2)和白细胞介素-15在使驻留的初始CD4 T细胞易受HIV感染方面起关键作用。记忆CD4 T细胞的感染也需要内源性可溶性因子,但不需要IL-2或IL-15。在对HIV感染敏感的组织驻留初始CD4 T细胞中,A3G以高分子质量复合物的形式存在,但在不敏感的、源自血液的初始CD4 T细胞中以低分子质量形式存在。用内源性可溶性因子处理后,这些细胞对HIV感染变得敏感,因为低分子质量的A3G被诱导组装成高分子质量复合物。这些发现表明,在淋巴组织中,内源性可溶性因子,可能包括IL-2、IL-15和其他因子,刺激组织驻留初始CD4 T细胞中高分子质量A3G复合物的形成,从而解除低分子质量A3G对HIV感染所赋予的强大的进入后限制障碍。